Mucinous adenocarcinoma of the cervix is a malignant tumor, and the treatment needs to be considered according to clinical stage, patient’s age and other factors, and usually adopts a comprehensive treatment plan which is mainly based on surgery and radiotherapy, supplemented by chemotherapy.
Cervical mucinous adenocarcinoma is a common pathological type of cervical adenocarcinoma, a malignant tumor originated from the columnar mucous cells of the cervical canal, which is mainly manifested by increased vaginal secretion sometimes in the form of watery or mucous, abnormal vaginal bleeding, etc. It can be classified into high, medium and low grade. It can be divided into highly, moderately and poorly differentiated adenocarcinoma. Appropriate individualized treatment plan is formulated based on a combination of factors such as clinical staging, patient’s age, fertility requirements, and systemic condition.
Those who can tolerate surgery and estimate that the lesion can be resected should strive for surgical treatment as much as possible. For those who have difficulty in surgery or are estimated to be difficult to remove, preoperative radiotherapy followed by surgery is recommended. A comprehensive treatment plan based on surgery and radiotherapy, supplemented by chemotherapy, is usually adopted. If mucinous adenocarcinoma of the uterine cervix is detected, it is necessary to go to the hospital for a comprehensive evaluation by a physician to guide an appropriate treatment plan to avoid delaying the condition.